Comparison of different series that utilized the Wingspan system in the treatment of symptomatic intracranial atherosclerotic disease
| Study | No of patients | No of lesions | Average stenosis (%) | 24 h symptomatic complications (n (%)) | 30 day stroke and death (%) | ISR*(≥50%) (%) |
| Henkes (2005)8 | 15 | 15 | 72 | 1 (6.6) | NA | NA |
| Bose (2007)4 | 45 | 44 | 74.9 | 0 | 4.5 | 0 |
| Fiorella (2007)3 | 78 | 82 | 74.6 | 5 (6.1) | NA | NA |
| Zaidat (2008)2 | 129 | 82 | 8 (6.2) | 9.6 | 15.3 | |
| Costalat (2011)9 | 60 | 63 | 80 | 3 (4.8) | 10 | 2 |
| Jiang (2011)10 | 100 | 105 | 79 | 4 (4) | 5 | 11.1 |
| Yu (2011)7 | 60 | 60 | 76 | 2 (3.3) | 8.3 | 3.3 |
| SAMMPRIS (2011)5 | 224 | 224 | 80 | 25 (11) | 14.7 | NA |
↵* Symptomatic ISR.
ISR, in-stent restenosis; NA, not available; SAMMPRIS, Stenting versus Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis.